Renalytix AI Plc enters a partnership with the University of Michigan

  • Jun 30, 2020 BST
  • Team Kalkine
Renalytix AI Plc enters a partnership with the University of Michigan

 

Renalytix AI Plc (LON: RENX) has announced a partnership with the University of Michigan.

  • The partnership is to extend the use of the KidneyIntelX™ platform to an enlarged population of patients with established CKD (Chronic Kidney Disease) or at risk of developing CKD.
  • Company’s first phase of the partnership with the University of Michigan, which will study the potential role of uEGF in further enhancing the prognostic performance of the KidneyIntelX platform in identifying patients at highest risk of fast-progressing DKD (Diabetic Kidney Disease) and kidney failure is expected to be completed in 2020.
  • On 30th June 2020, at the time of writing, GMT 08:56 AM, RENX shares were trading at GBX 530.00, down by 527.50 points or 0.47% against the previous day closing price.

 


Disclaimer
The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site.

 

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK